Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Acta Psychiatr Scand. 2024 Aug;150(2):91-104. doi: 10.1111/acps.13692. Epub 2024 Apr 21.
The aim of this study was to determine whether the clinical profiles of bipolar disorder (BD) patients could be differentiated more clearly using the existing classification by diagnostic subtype or by lithium treatment responsiveness.
We included adult patients with BD-I or II (N = 477 across four sites) who were treated with lithium as their principal mood stabilizer for at least 1 year. Treatment responsiveness was defined using the dichotomized Alda score. We performed hierarchical clustering on phenotypes defined by 40 features, covering demographics, clinical course, family history, suicide behaviour, and comorbid conditions. We then measured the amount of information that inferred clusters carried about (A) BD subtype and (B) lithium responsiveness using adjusted mutual information (AMI) scores. Detailed phenotypic profiles across clusters were then evaluated with univariate comparisons.
Two clusters were identified (n = 56 and n = 421), which captured significantly more information about lithium responsiveness (AMI range: 0.033 to 0.133) than BD subtype (AMI: 0.004 to 0.011). The smaller cluster had disproportionately more lithium responders (n = 47 [83.8%]) when compared to the larger cluster (103 [24.4%]; p = 0.006).
Phenotypes derived from detailed clinical data may carry more information about lithium responsiveness than the current classification of diagnostic subtype. These findings support lithium responsiveness as a valid approach to stratification in clinical samples.
本研究旨在确定使用现有的诊断亚型分类或锂治疗反应性,是否可以更清楚地区分双相情感障碍(BD)患者的临床特征。
我们纳入了在四个地点接受锂作为主要情绪稳定剂治疗至少 1 年的成人 BD-I 或 II 患者(共 477 名)。使用二分的 Alda 评分来定义治疗反应性。我们对涵盖人口统计学、临床过程、家族史、自杀行为和合并症的 40 个特征定义的表型进行层次聚类。然后,我们使用调整后的互信息(AMI)评分测量推断聚类携带的有关(A)BD 亚型和(B)锂反应性的信息量。然后使用单变量比较对聚类之间的详细表型谱进行评估。
确定了两个聚类(n=56 和 n=421),它们携带有关锂反应性的信息量明显更多(AMI 范围:0.033 至 0.133),而不是 BD 亚型(AMI:0.004 至 0.011)。与较大的聚类(103 [24.4%];p=0.006)相比,较小的聚类具有不成比例的更多锂反应者(n=47 [83.8%])。
从详细临床数据中得出的表型可能比当前的诊断亚型分类携带更多有关锂反应性的信息。这些发现支持锂反应性作为临床样本分层的有效方法。